503-222-1261 info@crgpdx.com

Hypertension Study

This is a study to evaluate the safety and efficacy of an investigational drug vs. placebo in patients with essential hypertension who are not adequately controlled by standard of care.  The trial lasts approximately 1 year and includes all study related care including the completion of 24 hour ambulatory blood pressure monitoring (ABPMs) at predetermined time points.  Financial compensation of up to $1525.00 is available for patients who complete all visits.  The estimated start date is October of 2017.